UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 0-28272

AVIGEN, INC.
(Exact name of registrant as specified in its charter)

1301 Harbor Bay Parkway
Alameda, California 94502
(510) 748-7150
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, par value $0.001 per share
Preferred Share Purchase Rights
(Title of each class of securities covered by this Form)

None
(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

      Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

                Rule 12g-4(a)(1)                       x
  Rule 12g-4(a)(2)    ¨
Rule 12h-3(b)(1)(i)   x
Rule 12h-3(b)(1)(ii)   ¨
Rule 15d-6   ¨

      Approximate number of holders as of the certification or notice date: One .

      Pursuant to the requirements of the Securities Exchange Act of 1934, Avigen, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date:   December 18, 2009   AVIGEN, INC.    
 
 
  By:                /s/  Shintaro Asako    
                Name:    Shintaro Asako    
    Title:      Chief Executive Officer    

Avigen (MM) (NASDAQ:AVGN)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Avigen (MM).
Avigen (MM) (NASDAQ:AVGN)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Avigen (MM).